LIN · Linde PLC - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · LIN

1Y 3Y 5Y Max

Annual Quarterly

Income Statement

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$33.99B	$33.01B	$32.85B	$33.36B	$30.79B	$27.24B
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
R&D	$147.00M	$150.00M	$146.00M	$143.00M	$143.00M	$152.00M
SG&A	$3.43B	$3.34B	$3.29B	$3.11B	$3.19B	$3.19B
Total Operating Expenses	-	-	-	-	-	-
D&A	$3.76B	$3.78B	$3.82B	$4.20B	$4.63B	$4.63B
Operating Income	$8.92B	$8.63B	$8.02B	$5.37B	$4.98B	$3.32B
Interest Expense	$575.00M	$555.00M	$480.00M	$277.00M	$227.00M	$277.00M
Income Tax	$1.99B	$2.00B	$1.81B	$1.43B	$1.26B	$847.00M
Net Income	$6.90B	$6.57B	$6.20B	$4.15B	$3.83B	$2.50B
EPS - Basic	$14.69	$13.71	$12.70	$8.30	$7.40	$4.75
EPS - Diluted	$14.61	$13.62	$12.59	$8.23	$7.33	$4.71

Balance Sheet

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & Equivalents	$5.06B	$4.85B	$4.66B	$5.44B	$2.82B	$3.75B
Accounts Receivable	$4.97B	$4.62B	$4.72B	$4.56B	$4.50B	$4.17B
Inventory	$2.06B	$1.95B	$2.12B	$1.98B	$1.73B	$1.73B
Accounts Payable	$2.81B	$2.51B	$3.02B	$3.00B	$3.50B	$3.10B
Current Assets	$13.32B	$12.95B	$12.62B	$13.05B	$10.16B	$10.92B
Total Assets	$86.82B	$80.15B	$80.81B	$79.66B	$81.61B	$88.23B
Current Liabilities	$15.20B	$14.54B	$15.72B	$16.48B	$13.64B	$13.74B
Long-term Debt	$20.68B	$15.34B	$13.40B	$12.20B	$11.34B	$12.15B
Total Liabilities	$47.08B	$40.66B	$39.72B	$38.27B	$36.16B	$38.65B
Stockholders' Equity	$38.24B	$38.09B	$39.72B	$40.03B	$44.03B	$47.32B
Retained Earnings	$16.61B	$12.63B	$8.85B	$20.54B	$18.71B	$17.18B

Cash Flow

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Operating Cash Flow	$10.35B	$9.42B	$9.30B	$7.43B	$9.72B	$7.43B
Investing Cash Flow	($5.72B)	($4.64B)	($4.67B)	($2.99B)	($3.01B)	($2.99B)
Financing Cash Flow	($4.55B)	($4.36B)	($5.40B)	($3.35B)	($7.59B)	($3.35B)
CapEx	$5.26B	$4.50B	$3.79B	$3.17B	$3.09B	$3.40B
Free Cash Flow	$5.09B	$4.93B	$5.52B	$4.26B	$6.64B	$4.03B

Ratios

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Profitability
Gross margin	-	-	-	-	-	-
Operating margin	26.3%	26.2%	24.4%	16.1%	16.2%	12.2%
EBITDA margin	37.3%	37.6%	36.0%	28.7%	31.2%	29.2%
Net margin	20.3%	19.9%	18.9%	12.4%	12.4%	9.2%
Free cash flow margin	15.0%	14.9%	16.8%	12.8%	21.6%	14.8%
FCF / Net income	0.74	0.75	0.89	1.03	1.74	1.61
R&D / Revenue	0.4%	0.5%	0.4%	0.4%	0.5%	0.6%
SG&A / Revenue	10.1%	10.1%	10.0%	9.3%	10.4%	11.7%
Effective tax rate	22.4%	23.4%	22.6%	25.7%	24.8%	25.3%
Return on assets	7.9%	8.2%	7.7%	5.2%	4.7%	2.8%
Return on equity	18.0%	17.2%	15.6%	10.4%	8.7%	5.3%
Return on invested capital	11.8%	12.4%	11.7%	7.6%	6.8%	4.2%
Liquidity
Current ratio	0.88	0.89	0.80	0.79	0.74	0.80
Quick ratio	0.74	0.76	0.67	0.67	0.62	0.67
Cash ratio	0.33	0.33	0.30	0.33	0.21	0.27
Leverage
Debt / Equity	0.54	0.40	0.34	0.30	0.26	0.26
Debt / Assets	0.24	0.19	0.17	0.15	0.14	0.14
Debt / EBITDA	1.63	1.24	1.13	1.27	1.18	1.53
Interest coverage	15.5x	15.6x	16.7x	19.4x	22.0x	12.0x
Equity multiplier	2.27	2.10	2.03	1.99	1.85	1.86
Liabilities / Assets	0.54	0.51	0.49	0.48	0.44	0.44
Efficiency
Asset turnover	0.39	0.41	0.41	0.42	0.38	0.31
Inventory turnover	-	-	-	-	-	-
Days sales outstanding	53d	51d	52d	50d	53d	56d
Days inventory outstanding	-	-	-	-	-	-
Days payable outstanding	-	-	-	-	-	-
Cash conversion cycle	-	-	-	-	-	-
Valuation
P / E	29.2x	30.7x	32.6x	39.6x	47.3x	55.9x
P / B	5.3x	5.3x	5.1x	4.1x	4.1x	3.0x
P / S	5.9x	6.1x	6.2x	4.9x	5.9x	5.1x
EV / EBITDA	17.1x	17.1x	17.8x	17.9x	19.7x	18.7x
Growth
Revenue growth (YoY)	3.0%	0.5%	-1.5%	8.3%	13.0%	-3.5%
Revenue CAGR (3y)	0.6%	2.3%	6.4%	5.7%	43.0%	-
Revenue CAGR (5y)	4.5%	3.2%	25.5%	-	-	-
Gross profit growth (YoY)	-	-	-	-	-	-
Operating income growth (YoY)	3.3%	7.6%	49.5%	7.7%	50.0%	13.3%
Net income growth (YoY)	5.1%	5.9%	49.5%	8.4%	53.0%	9.5%
EPS growth (YoY)	7.3%	8.2%	53.0%	12.3%	55.6%	12.4%
EPS CAGR (3y)	21.1%	22.9%	38.8%	25.2%	12.1%	-
EPS CAGR (5y)	25.4%	26.6%	19.3%	-	-	-
FCF growth (YoY)	3.3%	-10.7%	29.7%	-35.9%	64.8%	65.3%
FCF CAGR (5y)	4.8%	15.1%	33.0%	-	-	-
Book value growth (YoY)	0.4%	-4.1%	-0.8%	-9.1%	-6.9%	-3.6%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$33.99B total

Americas Segment$15.21B · 44.7%

EMEASegment$8.55B · 25.2%

APACSegment$6.66B · 19.6%

Engineering Segment$2.25B · 6.6%

Corporate And Other$1.32B · 3.9%

Geographic

$33.99B total

US$12.18B · 35.8%

Other International$11.26B · 33.1%

CN$2.60B · 7.7%

DE$2.43B · 7.2%

GB$1.51B · 4.4%

MX$1.39B · 4.1%

BR$1.32B · 3.9%

AU$1.29B · 3.8%

Stability scores

Altman Z′

FY 2025 · bankruptcy risk

1.20

Distress

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2025 · 9-point quality

4/9

Neutral

✓Net income positive
✓Operating cash flow positive
✗ROA improved YoY
✓Cash flow > net income
✗Long-term debt decreased
✗Current ratio improved
✓No share dilution
-Gross margin improved
✗Asset turnover improved

Peer comparison

Same SIC group: Industrial Inorganic Chemicals

Company	Revenue (last FY)	Net margin	ROE
MTX	$2.07B	-0.9%	-1.1%
APD	$12.04B	-3.3%	-2.6%
LTBR	$0	-	-9.6%
LXFR	$384.60M	2.0%	3.4%
LXU	$615.21M	4.0%	4.7%

Comparing LINDE PLC against the 5 most active filers in the same SIC group.

Dividends

$4.60/share trailing 12 months · -20.4% YoY

Ex-date	Per share
Mar 11, 2026	$1.6000
Dec 3, 2025	$1.5000
Sep 4, 2025	$1.5000
Jun 4, 2025	$1.5000
Mar 13, 2025	$1.5000
Dec 3, 2024	$1.3900
Sep 4, 2024	$1.3900
Jun 4, 2024	$1.3900
Mar 13, 2024	$1.3900
Dec 1, 2023	$1.2750
Sep 1, 2023	$1.2750
Jun 1, 2023	$1.2750
Mar 13, 2023	$1.2750
Dec 1, 2022	$1.1700
Sep 1, 2022	$1.1700
Jun 2, 2022	$1.1700
Mar 10, 2022	$1.1700
Dec 2, 2021	$1.0600
Sep 2, 2021	$1.0600
Jun 2, 2021	$1.0600
Mar 4, 2021	$1.0600
Dec 2, 2020	$0.9630
Sep 2, 2020	$0.9630
Jun 2, 2020	$0.9630